Hanqing Dong

6.1k total citations · 3 hit papers
51 papers, 4.8k citations indexed

About

Hanqing Dong is a scholar working on Molecular Biology, Organic Chemistry and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Hanqing Dong has authored 51 papers receiving a total of 4.8k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Molecular Biology, 19 papers in Organic Chemistry and 9 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Hanqing Dong's work include Protein Degradation and Inhibitors (16 papers), Ubiquitin and proteasome pathways (10 papers) and Prostate Cancer Treatment and Research (8 papers). Hanqing Dong is often cited by papers focused on Protein Degradation and Inhibitors (16 papers), Ubiquitin and proteasome pathways (10 papers) and Prostate Cancer Treatment and Research (8 papers). Hanqing Dong collaborates with scholars based in United States, China and Germany. Hanqing Dong's co-authors include Craig M. Crews, Yimin Qian, Andrew P. Crew, Jing Wang, Guo‐Qiang Lin, John Hines, Ping Tian, Kanak Raina, James D. Winkler and Kevin Coleman and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Oncology.

In The Last Decade

Hanqing Dong

50 papers receiving 4.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Hijacking the E3 Ubiquitin Ligase Cereblon to Efficiently Target BRD4

2015 849 citations Jing Lü, Yimin Qian et al. Chemistry & Biology profile →
PROTAC-induced BET protein degradation as a therapy for castration-resistant prostate cancer

2016 661 citations Kanak Raina, Jing Lü et al. Proceedings of the National Academy of Sciences profile →
The Advantages of Targeted Protein Degradation Over Inhibition: An RTK Case Study

2017 488 citations George M. Burslem, Blake E. Smith et al. Cell chemical biology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Hanqing Dong United States	29	3.4k	1.3k	1.0k	961	333	51	4.8k
Yujun Zhao China	33	2.6k 0.7×	1.1k 0.8×	1.7k 1.6×	406 0.4×	213 0.6×	106	5.2k
Steven W. Elmore United States	24	3.2k 0.9×	1.2k 0.9×	716 0.7×	510 0.5×	38 0.1×	37	4.8k
Andrew J. Souers United States	30	2.0k 0.6×	595 0.5×	685 0.7×	354 0.4×	81 0.2×	79	3.1k
Sylvie M. Guichard United Kingdom	33	2.3k 0.7×	1.6k 1.2×	555 0.5×	202 0.2×	80 0.2×	96	4.0k
Rosanna Supino Italy	37	3.0k 0.9×	1.7k 1.3×	593 0.6×	483 0.5×	55 0.2×	109	4.9k
Lawrence G. Hamann United States	32	1.8k 0.5×	498 0.4×	1.3k 1.2×	119 0.1×	185 0.6×	64	4.2k
Alan J. Kraker United States	34	2.7k 0.8×	2.2k 1.7×	1.2k 1.2×	351 0.4×	52 0.2×	46	4.8k
Liguang Lou China	36	1.9k 0.6×	1.5k 1.2×	697 0.7×	136 0.1×	46 0.1×	135	4.0k
Gordon W. Rewcastle New Zealand	35	2.4k 0.7×	1.2k 0.9×	2.4k 2.3×	192 0.2×	83 0.2×	107	4.7k
Athanasios Yiotakis Greece	34	1.7k 0.5×	1.3k 1.0×	1.1k 1.1×	172 0.2×	211 0.6×	74	3.1k

Countries citing papers authored by Hanqing Dong

Since Specialization

Citations

This map shows the geographic impact of Hanqing Dong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hanqing Dong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hanqing Dong more than expected).

Fields of papers citing papers by Hanqing Dong

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hanqing Dong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hanqing Dong. The network helps show where Hanqing Dong may publish in the future.

Co-authorship network of co-authors of Hanqing Dong

This figure shows the co-authorship network connecting the top 25 collaborators of Hanqing Dong. A scholar is included among the top collaborators of Hanqing Dong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hanqing Dong. Hanqing Dong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Dong, Hanqing, et al.. (2025). Sensor‐enabled Orthopedic Implants for Musculoskeletal Monitoring. Advanced Sensor Research. 4(4). 4 indexed citations

Dong, Hanqing, et al.. (2021). Evaluating Ligands for Ubiquitin Ligases Using Affinity Beads. Methods in molecular biology. 2365. 59–75. 1 indexed citations

Alabi, Shanique, Ryan R. Willard, Jing Wang, et al.. (2018). Androgen receptor degradation by the proteolysis-targeting chimera ARCC-4 outperforms enzalutamide in cellular models of prostate cancer drug resistance. Communications Biology. 1(1). 100–100. 273 indexed citations

Hines, John, et al.. (2018). MDM2-Recruiting PROTAC Offers Superior, Synergistic Antiproliferative Activity via Simultaneous Degradation of BRD4 and Stabilization of p53. Cancer Research. 79(1). 251–262. 258 indexed citations

Burslem, George M., Blake E. Smith, Saul Jaime‐Figueroa, et al.. (2017). The Advantages of Targeted Protein Degradation Over Inhibition: An RTK Case Study. Cell chemical biology. 25(1). 67–77.e3. 488 indexed citations breakdown →

Raina, Kanak, Jing Lü, Yimin Qian, et al.. (2016). PROTAC-induced BET protein degradation as a therapy for castration-resistant prostate cancer. Proceedings of the National Academy of Sciences. 113(26). 7124–7129. 661 indexed citations breakdown →

Lü, Jing, Yimin Qian, Martha Altieri, et al.. (2015). Hijacking the E3 Ubiquitin Ligase Cereblon to Efficiently Target BRD4. Chemistry & Biology. 22(6). 755–763. 849 indexed citations breakdown →

Vigil, Dominico, Tai Young Kim, Andrew J. Garton, et al.. (2012). ROCK1 and ROCK2 Are Required for Non-Small Cell Lung Cancer Anchorage-Independent Growth and Invasion. Cancer Research. 72(20). 5338–5347. 109 indexed citations

Fontana, Luis, Enpeng Zhao, Muhammad Amir, et al.. (2012). Aging promotes the development of diet-induced murine steatohepatitis but not steatosis. Hepatology. 57(3). 995–1004. 99 indexed citations

10.

Dong, Hanqing & Mark J. Czaja. (2011). Regulation of lipid droplets by autophagy. Trends in Endocrinology and Metabolism. 22(6). 234–240. 185 indexed citations

11.

Tian, Ping, Hanqing Dong, & Guo‐Qiang Lin. (2011). Rhodium-Catalyzed Asymmetric Arylation. ACS Catalysis. 2(1). 95–119. 393 indexed citations

12.

Jin, Meizhong, Prafulla C. Gokhale, Kenneth W. Foreman, et al.. (2010). Potent and selective cyclohexyl-derived imidazopyrazine insulin-like growth factor 1 receptor inhibitors with in vivo efficacy. Bioorganic & Medicinal Chemistry Letters. 21(4). 1176–1180. 13 indexed citations

13.

Dong, Hanqing, Wenwei Lin, Jing Wu, & Taosheng Chen. (2010). Flavonoids activate pregnane × receptor-mediated CYP3A4 gene expression by inhibiting cyclin-dependent kinases in HepG2 liver carcinoma cells. BMC Biochemistry. 11(1). 23–23. 64 indexed citations

14.

Dong, Hanqing, et al.. (2009). Glycogen synthase kinase 3 regulates PAX3–FKHR-mediated cell proliferation in human alveolar rhabdomyosarcoma cells. Biochemical and Biophysical Research Communications. 391(1). 1049–1055. 40 indexed citations

15.

Pondugula, Satyanarayana R., Hanqing Dong, & Taosheng Chen. (2009). Phosphorylation and protein–protein interactions in PXR-mediated CYP3A repression. Expert Opinion on Drug Metabolism & Toxicology. 5(8). 861–873. 60 indexed citations

16.

Lin, Wenwei, et al.. (2008). Cyclin-dependent Kinase 2 Negatively Regulates Human Pregnane X Receptor-mediated CYP3A4 Gene Expression in HepG2 Liver Carcinoma Cells. Journal of Biological Chemistry. 283(45). 30650–30657. 92 indexed citations

17.

Mulvihill, Mark J., Qunsheng Ji, Heather Coate, et al.. (2007). Novel 2-phenylquinolin-7-yl-derived imidazo[1,5-a]pyrazines as potent insulin-like growth factor-I receptor (IGF-IR) inhibitors. Bioorganic & Medicinal Chemistry. 16(3). 1359–1375. 59 indexed citations

18.

Li, An‐Hu, Xin Chen, Matthew Cox, et al.. (2006). A highly effective one-pot synthesis of quinolines from o-nitroarylcarbaldehydes. Organic & Biomolecular Chemistry. 5(1). 61–64. 72 indexed citations

19.

Mulvihill, Mark J., Qunsheng Ji, Patricia Beck, et al.. (2006). 1,3-Disubstituted-imidazo[1,5-a]pyrazines as insulin-like growth-factor-I receptor (IGF-IR) inhibitors. Bioorganic & Medicinal Chemistry Letters. 17(4). 1091–1097. 23 indexed citations

20.

Castelhano, Arlindo L., Hanqing Dong, Matthew C. T. Fyfe, et al.. (2005). Glucokinase-activating ureas. Bioorganic & Medicinal Chemistry Letters. 15(5). 1501–1504. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact